Your browser doesn't support javascript.
loading
The impact of the distance traveled between residence and gestational trophoblastic neoplasia reference center and clinical outcomes in Brazilian women.
Braga, Antonio; Lopes, Renata; Campos, Vanessa; Freitas, Fernanda; Maestá, Izildinha; Sun, Sue Yazaki; Pedrotti, Luana Giongo; Bessel, Marina; de Sousa, Christiani Bisinoto; Leal, Elaine; Yela, Daniela; Uberti, Elza; Madi, José Mauro; Viggiano, Mauricio; Junior, Joffre Amim; Filho, Jorge Rezende; Elias, Kevin M; Horowitz, Neil S; Berkowitz, Ross S.
Afiliación
  • Braga A; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Lopes R; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Campos V; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Freitas F; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Maestá I; Botucatu Trophoblastic Disease Center of the Clinical Hospital of Botucatu Medical School, Department of Gynecology and Obstetrics, São Paulo State University - UNESP, Botucatu, SP, Brazil.
  • Sun SY; Departament of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Pedrotti LG; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • Bessel M; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil.
  • de Sousa CB; Universidade de São Paulo, Hospital das Clínicas of the Ribeirão Preto School of Medicine, Department of Gynecology and Obstetrics, Ribeirão Preto, SP, Brazil.
  • Leal E; Rio Branco Trophoblastic Disease Center, Clinics Hospital of Acre, Rio Branco, AC, Brazil.
  • Yela D; Campinas Trophoblastic Disease Center, University of Campinas, Campinas, SP, Brazil.
  • Uberti E; Porto Alegre Trophoblastic Disease Center, Mario Totta Maternity Ward, Irmandade da Santa Casa de Misericórdia Hospital, Porto Alegre, RS, Brazil.
  • Madi JM; Caxias do Sul Trophoblastic Disease Center, General Hospital of Caxias do Sul, School of Medicine, Center for Biological and Health Sciences, Caxias do Sul University, Caxias do Sul, RS, Brazil.
  • Viggiano M; Goiania Trophoblastic Disease Center (Clinics Hospital of Goias Federal University), Goiania, GO, Brazil.
  • Junior JA; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Filho JR; Rio de Janeiro Trophoblastic Disease Center (Maternity School of Rio de Janeiro Federal University, Antonio Pedro University Hospital of Fluminense Federal University), Postgraduate Program in Perinatal Health, Faculty of Medicine, Maternity School of Rio de Janeiro Federal University, Rio de Janeir
  • Elias KM; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Horowitz NS; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Berkowitz RS; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Gynecol Oncol ; 176: 130-138, 2023 09.
Article en En | MEDLINE | ID: mdl-37524011
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Trofoblástica Gestacional / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: America do sul / Brasil Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad Trofoblástica Gestacional / Recurrencia Local de Neoplasia Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Pregnancy País/Región como asunto: America do sul / Brasil Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article